Breakthrough melanoma treatment saves grandfather’s eyesight
Blind in his left eye after a stroke three years ago, 70 year old Geoff was fully reliant on his right eye.
Visitor information – Everything you need to know about visiting our sites.
Blind in his left eye after a stroke three years ago, 70 year old Geoff was fully reliant on his right eye.
A world-first study, for which The Alfred is the Victorian lead, is using 3D skin imaging technology and artificial intelligence to significantly improve the early detection of melanoma for all Australians.
Work on the $152.4 million Paula Fox Melanoma and Cancer Centre has reached a major milestone, with the building structure reaching its highest point at level seven.
A first in the world trial looking at new treatment options for patients with melanoma that has spread to the brain is set to commence at The Alfred, potentially helping patients add years to their lives.
Promoting skin cancer awareness amongst Victorian construction workers is the focus of a new initiative that was launched at the site of the new Paula Fox Melanoma and Cancer Centre today.
For pancreatic cancer patients, clinical trials run at The Alfred can offer new hope in addition to conventional forms of treatment.
Biological differences between men and women can have an impact on the success of melanoma treatment, according to new research co-led by Alfred oncologist Miles Andrews.
Cancer care for Australians is set to be transformed as building starts on the Paula Fox Melanoma and Cancer Centre at The Alfred.
Victorians at risk of melanoma now have access to cutting-edge 3D whole body imaging, which promises to improve detection and management of the deadly cancer.
“The Alfred Cancer Trials unit is progressive, innovative, supportive, and driven – it’s a dynamic environment to be in, and that’s what excites me.”